Evidence map›Paper›PMID 36506132›Full record

ArticleACS omega2022

Novel 5-(Arylideneamino)-1

Sardar Ali, Mumtaz Ali, Ajmal Khan, Saeed Ullah, Muhammad Waqas, Ahmed Al-Harrasi, Abdul Latif, Manzoor Ahmad, Muhammad Saadiq

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Identification of Antioxidant Methyl Derivatives ofInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sardar AliDepartment of Chemistry, University of Malakand, Dir Lower, Chakdara 18800 Khyber Pakhtunkhwa, Pakistan.ORCID https://orcid.org/0000-0001-6514-4003
Mumtaz AliDepartment of Chemistry, University of Malakand, Dir Lower, Chakdara 18800 Khyber Pakhtunkhwa, Pakistan.ORCID https://orcid.org/0000-0001-7573-7953
Ajmal KhanNatural and Medical Sciences Research Center, University of Nizwa, P.O. Box 33, Birkat Al Mauz, Nizwa 616, Oman.
Saeed UllahNatural and Medical Sciences Research Center, University of Nizwa, P.O. Box 33, Birkat Al Mauz, Nizwa 616, Oman.
Muhammad WaqasNatural and Medical Sciences Research Center, University of Nizwa, P.O. Box 33, Birkat Al Mauz, Nizwa 616, Oman.
Ahmed Al-HarrasiNatural and Medical Sciences Research Center, University of Nizwa, P.O. Box 33, Birkat Al Mauz, Nizwa 616, Oman.ORCID https://orcid.org/0000-0002-0815-5942
Abdul LatifDepartment of Chemistry, University of Malakand, Dir Lower, Chakdara 18800 Khyber Pakhtunkhwa, Pakistan.
Manzoor AhmadDepartment of Chemistry, University of Malakand, Dir Lower, Chakdara 18800 Khyber Pakhtunkhwa, Pakistan.ORCID https://orcid.org/0000-0001-9736-5900
Muhammad SaadiqDepartment of Chemistry, Bacha Khan University, Charsadda 18800 Khyber Pakhtunkhwa, Pakistan.ORCID https://orcid.org/0000-0002-4963-4341

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel series of multifunctional benzimidazoles has been reported as potent inhibitors of α-glucosidase. The procedure relies on the synthesis of 5-amino-1

Identifiers

PMID36506132
PMCPMC9730482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.